Net income · 2011–2025

Iovance Biotherapeutics net income

−$391M−$18.8M · FY2025

Iovance Biotherapeutics (IOVA) reported −$391M in net income for fiscal 2025, −$18.8M from the year before.

−$25.7M2011−$3.3M2012−$25.4M2013−$12.0M2014−$27.7M2015−$52.9M2016−$92.1M2017−$124M2018−$198M2019−$260M2020−$342M2021−$396M2022−$444M2023−$372M2024−$391M2025
Iovance Biotherapeutics — Net income, 2011–2025
Fiscal yearNet incomeChangeFiling
FY20252025-12-31−$391M−$18.8MOpen →
FY20242024-12-31−$372M+$71.8MOpen →
FY20232023-12-31−$444M−$48.1MOpen →
FY20222022-12-31−$396M−$53.6MOpen →
FY20212021-12-31−$342M−$82.7MOpen →
FY20202020-12-31−$260M−$62.0MOpen →
FY20192019-12-31−$198M−$74.0MOpen →
FY20182018-12-31−$124M−$31.5MOpen →
FY20172017-12-31−$92.1M−$39.2MOpen →
FY20162016-12-31−$52.9M−$25.2MOpen →
FY20152015-12-31−$27.7M−$15.6MOpen →
FY20142014-12-31−$12.0M+$13.3MOpen →
FY20132013-12-31−$25.4M−$22.1MOpen →
FY20122012-12-31−$3.3M+$22.4MOpen →
FY20112011-12-31−$25.7M—Open →

Net income — Net income is profit after tax and all expenses, as reported in the annual filing. Companies reporting a loss are excluded from this ranking.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Net income at companies of similar size

Full ranking by net income →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Iovance Biotherapeutics net income |url=https://companiesranked.com/en/company/iovance-biotherapeutics/net-income |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Iovance Biotherapeutics net income. CompaniesRanked. https://companiesranked.com/en/company/iovance-biotherapeutics/net-income

BibTeX

@misc{companiesranked-en-company-iovance-biotherapeutics-net-income-2026,
  author       = {{CompaniesRanked}},
  title        = {{Iovance Biotherapeutics net income}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/iovance-biotherapeutics/net-income}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Iovance Biotherapeutics overview